Oncology Nutrition: Global $2.21 Billion Market Analysis by Cancer Type and Geography - Forecast to 2023 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jul 6, 2018--The “Oncology Nutrition Market by Cancer Type (Head & Neck, Stomach & Gastrointestinal, Liver, Pancreatic, Esophageal, Lung, Breast, Blood) - Global Forecast to 2023” report has been added to ResearchAndMarkets.com’s offering.
The global oncology nutrition market is expected to reach USD 2.21 Billion by 2023 from USD 1.46 Billion in 2018, at a CAGR of 8.7%.
Factors such as shifting focus from parenteral to enteral nutrition, increasing incidence of cancer, growing demand for nutritional feeding in the homecare sector, rising number of patients being treated for malnutrition, and increasing quality of clinical research on nutritional interventions are driving the market growth.
Based on cancer type, the head and neck cancers segment accounted for the largest share of the market in 2017. Patients with head and neck cancers suffer from severe problems associated with oral nutritional intake. Thus, the enteral route is used for nutrition support. With the increasing number of such cancers cases, the uptake of tube feeding formulas has increased. Also, conditions such as severe mucositis, xerostomia, dysgeusia, and nausea & vomiting limit nutritional intake, adding to the adoption of oncology nutritional feeding formulas.
Although, tube feeding is an effective and cost-efficient option for providing clinical nutrition, certain complications associated with the use of these devices can result in additional healthcare costs. Also, the limited reimbursement associated with its use pose significant restraint for greater adoption of these feeding formulas.
Geographically, the oncology nutrition market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2017, North America accounted for the largest share of this market. However, the Asia Pacific region is expected to witness the highest CAGR during the forecast period of 2018 to 2023. The growth of this segment can be attributed to the increased awareness and accessibility to advanced healthcare facilities, rising healthcare spending, large population base, and rapid improvements in the health insurance sector.
Companies ProfiledAbbott Laboratories B. Braun Danone Fresenius Kabi Nestle
Key Topics Covered
2 Research Methodology
3 Market Dynamics
4 Industry Insights
5 Global Oncology Nutritional Feeding Formulas Market, By Cancer Type
6 Product Portfolio Assessment
7 Company Profiles
8 Market Share Analysis
For more information about this report visit https://www.researchandmarkets.com/research/t62fmq/oncology?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180706005372/en/
Laura Wood, Senior Manager
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH FITNESS & NUTRITION ONCOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 07/06/2018 01:51 PM/DISC: 07/06/2018 01:50 PM